Even if not billion-dollar transactions, there are some interesting deals unfolding in the in vitro diagnostics (IVD) marketplace. Last month, HYCOR Biomedical, Inc., of Garden Grove, California, sold its Kova urinalysis system and business “to an affiliate of One Rock Capital Partners, Laurel Crown Partners, and StoneCreek Capital,” according to a Hycor press release. As …
March 4, 2013 “Intelligence: Late-Breaking Lab News” Read More »
